High DLL4 expression in tumour-associated vessels predicts for favorable radiotherapy outcome in locally advanced squamous cell head-neck cancer (HNSCC)

Angiogenesis

Volumn 16, Issue 2, 2013, Pages 343-351

  Koukourakis, Michael I ^a   Giatromanolaki, Alexandra ^a   Sivridis, Efthimios ^a   Gatter, Kevin C ^b   Harris, Adrian L ^b  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; CD31; DLL4; Head neck cancer; Radiotherapy

Indexed keywords

CD31 ANTIGEN; CISPLATIN; NOTCH RECEPTOR; OXALIPLATIN; PROTEIN DLL4; UNCLASSIFIED DRUG;

ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CAPILLARY DENSITY; CHEMORADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DISTANT METASTASIS FREE SURVIVAL; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84879508128     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-012-9318-5     Document Type: Article

References (27)

1. Sivridis E, Giatromanolaki A, Koukourakis MI (2003) The vascular network of tumours-what is it not for? J Pathol 201:173-180 (Pubitemid 37258927)
2. Foote RL, Weidner N, Harris J et al (2005) Evaluation of tumor angiogenesis measured with microvessel density (MVD) as a prognostic indicator in nasopharyngeal carcinoma: results of RTOG 9505. Int J Radiat Oncol Biol Phys 61:745-753 (Pubitemid 40247969)
3. Koukourakis MI, Giatromanolaki A, Fountzilas G et al (2000) Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy. Clin Cancer Res 6:381-389 (Pubitemid 30111454)
4. Beatrice F, Cammarota R, Giordano C et al (1998) Angiogenesis: prognostic significance in laryngeal cancer. Anticancer Res 18:4737-4740 (Pubitemid 29042053)
5. Koukourakis MI, Giatromanolaki A, Sivridis E et al (2001) Squamous cell head and neck cancer: evidence of angiogenic regeneration during radiotherapy. Anticancer Res 21:4301-4309
6. Lövey J, Lukits J, Remenár E et al (2006) Antiangiogenic effects of radiotherapy but not initial microvessel density predict survival in inoperable oropharyngeal squamous cell carcinoma. Strahlenther Onkol 182:149-156
7. Gorski DH, Beckett MA, Jaskowiak NT et al (1999) Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res 59:3374-3378 (Pubitemid 29334495)
8. Shintani S, Kiyota A, Mihara M et al (2000) Association of preoperative radiation effect with tumor angiogenesis and vascular endothelial growth factor in oral squamous cell carcinoma. Jpn J Cancer Res 91:1051-1057
9. Koukourakis MI, Giatromanolaki A, Sivridis E et al (2000) Cancer vascularization: implications in radiotherapy? Int J Radiat Oncol Biol Phys 48:545-553
10. Koukourakis MI, Giatromanolaki A, Sivridis E et al (2001) Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. Clin Cancer Res 7:3399-4303
11. Giatromanolaki A, Koukourakis MI, Georgoulias V et al (1999) Angiogenesis versus response after combined chemoradiotherapy of squamous cell head and neck cancer. Int J Cancer 80:810-817 (Pubitemid 29108853)
12. Takagi S, Inenaga R, Oya R et al (2006) Blood vessel density correlates with the effects of targeted intra-arterial carboplatin infusion with concurrent radiotherapy for squamous cell carcinomas of the oral cavity and oropharynx. Br J Cancer 94:1580-1585 (Pubitemid 43924917)
13. Willett CG, Boucher Y, di Tomaso E et al (2004) Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 10:145-147 (Pubitemid 38524883)
14. Bicknell R, Harris AL (2004) Novel angiogenic signaling pathways and vascular targets. Annu Rev Pharmacol Toxicol 44:219-238 (Pubitemid 38263840)
15. Gale NW, Dominguez MG, Noguera I et al (2004) Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci U S A 101:15949-15954 (Pubitemid 39507907)
16. Phng LK, Gerhardt H (2009) Angiogenesis: a team effort coordinated by notch. Dev Cell 16:196-208
17. Patel NS, Dobbie MS, Rochester M et al (2006) Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer. Clin Cancer Res 12:4836-4844 (Pubitemid 44338568)
18. Koukourakis MI, Tsoutsou PG, Karpouzis A et al (2010) Radiochemotherapy with cetuximab, cisplatin, and amifostine for locally advanced head and neck cancer: a feasibility study. Int J Radiat Oncol Biol Phys 77:9-15
19. Jubb AM, Soilleux EJ, Turley H et al (2010) Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer. Am J Pathol 176:2019-2028
20. Koukourakis MI, Giatromanolaki A, Tsakmaki V et al (2012) Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer. Br J Cancer 106:846-853
21. Koukourakis MI, Giatromanolaki A, Winter S et al (2009) Lactate dehydrogenase 5 expression in squamous cell head and neck cancer relates to prognosis following radical or postoperative radiotherapy. Oncology 77:285-292
22. Li JL, Sainson RC, Shi W et al (2007) Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Cancer Res 67:11244-11253 (Pubitemid 350248550)
23. Garcia-Barros M, Paris F, Cordon-Cardo C et al (2003) Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300:1155-1159 (Pubitemid 36583102)
24. Semenza GL, Jiang BH, Leung SW et al (1996) Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271:32529-32537 (Pubitemid 27008669)
25. Shih IeM, Wang TL (2007) Notch signaling, gamma-secretase inhibitors, and cancer therapy. Cancer Res 7:1879-1882
26. Liu SK, Bham SA, Fokas E et al (2011) Delta-like ligand 4-notch blockade and tumor radiation response. J Natl Cancer Inst 103:1778-1798
27. Thorwarth D, Eschmann SM, Scheiderbauer J et al (2005) Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer. BMC Cancer 5:152 (Pubitemid 41800127)